1 January 2023 in Computational and Structural Biotechnology Journal
Normal tissues are essential for studying disease-specific differential gene expression. However, healthy human controls are typically available only in postmortal/autopsy settings. In cancer research, fragments of pathologically normal tissue adjacent to tumor site are frequently used as the controls. However, it is largely underexplored how cancers can systematically influence gene expression of the neighboring tissues. Here we performed a comprehensive pan-cancer comparison of molecular profiles of solid tumor-adjacent and autopsy-derived “healthy” normal tissues. We found a number of systemic molecular differences related to activation of the immune cells, intracellular transport and autophagy, cellular respiration, telomerase activation, p38 signaling, cytoskeleton remodeling, and reorganization of the extracellular matrix. The tumor-adjacent tissues were deficient in apoptotic signaling and negative regulation of cell growth including G2/M cell cycle transition checkpoint. We also detected an extensive rearrangement of the chemical perception network. Molecular targets of 32 and 37 cancer drugs were over- or underexpressed, respectively, in the tumor-adjacent norms. These processes may be driven by molecular events that are correlated between the paired cancer and adjacent normal tissues, that mostly relate to inflammation and regulation of intracellular molecular pathways such as the p38, MAPK, Notch, and IGF1 signaling. However, using a model of macaque postmortal tissues we showed that for the 30 min – 24-hour time frame at 4ºC, an RNA degradation pattern in lung biosamples resulted in an artifact “differential” expression profile for 1140 genes, although no differences could be detected in liver. Thus, such concerns should be addressed in practice.
16 March 2021 in Urology Herald
Комбинация ретроградной и антеградной контактной электроимпульсной литотрипсии при камнях почки и лоханочномочеточникового сегмента
23 December 2020 in Urology Herald
Introduction. There remains a need to introduce new methods of treating kidney stones, given the increasing incidence of urolithiasis. Considering the proven efficacy and safety of retrograde electro-pulse lithotripsy, its use in the treatment of stones in the ureter, kidney and bladder, the need to expand the scope of this method is substantiated. Namely, the use in the treatment of kidney stones and the ureteropelvic junction with percutaneous approach.Purpose of the study. Assessment of the destruction effectiveness of kidney stones using an electro-pulse lithotripsy apparatus through antegrade (percutaneous) approach.Materials and methods. 229 percutaneous nephrolithotripsies were performed in patients with different locations of kidney stones in Siberian State Medical University Clinics (Tomsk, Russia) period from 2014 to 2019. We used the Urolit-105M electro-pulse lithotripter (Lithotech Medical, Israel, MedLine LLC, Russia) or the Calculase II laser lithotripter in some cases (Storz, Germany).Results. Patients were aged from 24 to 81 (women - 59.8%). The stones average size was 22 mm (from 10 to 73 mm). The stones average density was 1051.1 HU (from 360 to 1720 HU). The operation average duration was 122.3 minutes (from 40 to 300 minutes). The incidence of complications was 14.3%. The complete stones destruction occurred in 76% cases and that in combination with the laser went up to 89.95%. The overall response rate in redo operations reached 98.2%.Conclusion. Application of the electro-pulse method of kidney stone destruction with the percutaneous approach is makes a great effect, which is much higher when the stones is treated by the laser energy. Furthermore, combing with flexible endoscopes enables to apply the electro-pulse lithotripsy antegradely in hard-to-reach spots of the kidney cavitary system with no extra access to be provided. The method also enables to fight efficiently with the ureter upper part stones, also in combination with the retrograde approach to the stones.